Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 1/20 | 0.60 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.60 |
| ▸ | TP53 | P04637 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.60 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.60 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | HPGD | P15428 | 1/20 | 0.60 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29047905 | 1.00 | ADORA2A (0.60) | ADORA2AADORA2BTP53CYP3A4TSHR | |
| SCHEMBL453952 | 0.93 | ADORA2A (0.57) | ADORA2AADORA2BTP53CYP3A4TSHR | |
| SCHEMBL29421357 | 0.93 | ADORA2A (0.57) | ADORA2AADORA2BTP53CYP3A4TSHR | |
| SCHEMBL453953 | 0.93 | ADORA2A (0.57) | ADORA2AADORA2BTP53CYP3A4TSHR | |
| SCHEMBL453954 | 0.93 | ADORA2A (0.57) | ADORA2AADORA2BTP53CYP3A4TSHR | |
| SCHEMBL2480941 | 0.92 | ADORA2A (0.62) | ADORA2AADORA2BTP53CYP3A4TSHR | |
| SCHEMBL28964452 | 0.92 | ADORA2A (0.56) | ADORA2AADORA2BTP53CYP3A4TSHR | |
| SCHEMBL28964455 | 0.92 | ADORA2A (0.56) | ADORA2AADORA2BTP53CYP3A4TSHR | |
| SCHEMBL3692894 | 0.92 | PRMT5 (0.60) | ADORA2AADORA2BTP53CYP3A4TSHR | |
| SCHEMBL28659436 | 0.91 | SLC29A1 (0.58) | TP53CYP3A4TSHRALOX12NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119768533-A | Improved method for in vitro transcription | 阿克丘勒斯治疗公司 | 2025-04-04 | — | — | CN | disclosed |
| CN-118900701-A | Poly (alkyl oxazoline) -lipid conjugates and compositions containing poly (alkyl oxazoline) lipid particles of (alkyl oxazoline) -lipid conjugates | 盖纳万科学有限公司 | 2024-11-05 | — | — | CN | disclosed |
| CN-118786215-A | Analysis of RNA molecules using catalytic nucleic acids | 生物技术欧洲股份公司 | 2024-10-15 | — | — | CN | disclosed |
| CN-118613500-A | Modified mRNA treatment | 沙塔克实验室有限公司 | 2024-09-06 | — | — | CN | disclosed |
| CN-118103516-A | Modified replicable RNAs and related compositions and uses thereof | 生物技术欧洲股份公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-118019846-A | Compositions comprising CRISPR nucleases and uses thereof | 阿伯生物技术公司 | 2024-05-10 | — | — | CN | disclosed |
| CN-117940158-A | Novel lipid nanoparticles comprising phosphatidylserine for nucleic acid delivery | 库瑞瓦格欧洲公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-117940118-A | Novel lipid nanoparticles for nucleic acid delivery | 库瑞瓦格欧洲公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-117897485-A | RNA-guided gene editing system comprising a target hydroxy acid oxidase 1 (HAO 1) and uses thereof | 阿伯生物技术公司 | 2024-04-16 | — | — | CN | disclosed |
| CN-117813379-A | Gene editing system comprising CRISPR nucleases and uses thereof | 阿伯生物技术公司 | 2024-04-02 | — | — | CN | disclosed |
| CN-117295816-A | Compositions comprising variant polypeptides and uses thereof | 阿伯生物技术公司 | 2023-12-26 | — | — | CN | disclosed |
| CN-117136233-A | Compositions comprising variant Cas12i4 polypeptides and uses thereof | 阿伯生物技术公司 | 2023-11-28 | — | — | CN | disclosed |
| CN-117043326-A | Compositions comprising variant polypeptides and uses thereof | 阿伯生物技术公司 | 2023-11-10 | — | — | CN | disclosed |
| CN-116867898-A | Compositions comprising TRAC-targeted RNA guides and uses thereof | 阿伯生物技术公司 | 2023-10-10 | — | — | CN | disclosed |
| CN-116648505-A | Compositions comprising B2M-targeted RNA guides and uses thereof | 阿伯生物技术公司 | 2023-08-25 | — | — | CN | disclosed |
| CN-116601292-A | Compositions comprising RNA guides targeting BCL11A and uses thereof | 阿伯生物技术公司 | 2023-08-15 | — | — | CN | disclosed |
| CN-116157520-A | Compositions and methods for genome editing | 塑造治疗公司 | 2023-05-23 | — | — | CN | disclosed |
| CN-116134020-A | Lipid compounds comprising at least one terminal group of formula-NH-CX-A or-NH-CX-NH-A, compositions containing them and uses thereof | 赛诺菲巴斯德有限公司 | 2023-05-16 | — | — | CN | disclosed |
| CN-116064623-A | Method for increasing replication of circular DNA molecules | 库瑞瓦格制造业有限公司 | 2023-05-05 | — | — | CN | disclosed |
| CN-115361954-A | Compositions for translation and methods of use thereof | 旗舰创业创新第六有限责任公司 | 2022-11-18 | — | — | CN | disclosed |